Results

Total Results: 1,655 records

Showing results for "applicable".

101. Misuse of Prescription Stimulants in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
     September 13, 2024 - Other Limiters English language N/A N/A = not applicable Recent relevant systematic reviews and … • Exposure  Specific prescription stimulant(s), if named • Comparator, if applicable • Outcome o

102. Telehealth for Women (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/telehealth-women-protocol.pdf
     June 21, 2021 - For this review, the term women is used in a biological context, where applicable (e.g., individuals … conducted in the U.S. or in populations similar to U.S. populations, w ith services and interventions applicable … medium, or high level of study limitations) • Consistency (consistent, inconsistent, or unknown/not applicable … For these reasons the SOE approach planned for the other KQs is unlikely to be applicable. … will assess the fit of the GRADE-CERQual approach to our included studies for these questions.49 If applicable

103. Template for Draft Reports (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/long-term-care-adults-future_research.pdf
     July 01, 2013 - Cohort studies are less resource intensive and produce applicable results. … HCBS = home and community-based services; LTC = long-term care; NA = not applicable; NH = nursing home … LTC = long-term care; HCBS = home and community-based services; NA = not applicable; NH = nursing home … Cohort studies, alternatively, are less resource-intensive and produce applicable results. … Intervention Not applicable Comparator Not applicable Outcomes Subsequent use of LTC services, especially

104. Gastric-Cancers-Supplementary-App-D (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-supplementary-app-d.xlsx
     January 01, 2023 - ROB 2 Study name Applicable outcome Randomization process Deviations from intended interventions Missing … Some concerns concerns with baseline differences and randomization/allocation ROBINS-I Study name Applicable

105. Depression-Postpartum-Screening Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_executive.pdf
     May 01, 2013 - Delivery vs. 6 weeks 1 (113) High NA Direct Imprecise Insufficient CI = confidence interval; NA = not applicable … for increased number of visits for infants of screened women CI = confidence interval; NA = not applicable … higher rates of referral/diagnosis during delivery admission CI = confidence interval; NA = not applicable … less than 20 percent of well-child visits in the United States, these results may not be directly applicable … is similar overall to that in other women of reproductive age, these recommendations should be as applicable

106. Renal Artery Stenosis Management Strategies: An Updated Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-update_disposition-comments.pdf
     August 16, 2016 - We did change "not necessarily [applicable] to the majority of patients undergoing PTRAS" to "possibly … Throughout the key messages are clearly stated and applicable. … Peer Reviewer #3 Discussion/ Conclusion The major findings are clearly stated and widely applicable … PTRAS is based on “low strength of evidence”, and most importantly, “is most applicable to those patients … We have used some of this language to describe the enrolled/applicable patients.

107. Decision Modeling (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-decision-modeling.ppt
     June 01, 2012 - Studies (3 of 3) If previous modeling studies meet these three criteria — that they are high quality, applicable … to the interventions and populations of interest, and contain parameters that are applicable — then … Finally, the literature used for an evidence report might not be applicable to the development or adaptation … AD = Alzheimer’s disease MCI = mild cognitive impairment PET = positron emission tomography *When applicable … *When applicable; in this case, the harms of testing are not deemed important enough to consider in the

108. Decision Modeling (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-decision-modeling.ppt
     June 01, 2012 - Studies (3 of 3) If previous modeling studies meet these three criteria — that they are high quality, applicable … to the interventions and populations of interest, and contain parameters that are applicable — then … Finally, the literature used for an evidence report might not be applicable to the development or adaptation … AD = Alzheimer’s disease MCI = mild cognitive impairment PET = positron emission tomography *When applicable … *When applicable; in this case, the harms of testing are not deemed important enough to consider in the

109. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - domains: risk of bias (low, medium, or high), consistency (consistent, inconsistent, or unknown/not applicable … coronary angioplasty 23 Medications Registered or Trademark Name Generic Name (if applicable … when PCI is planned within 24 hr 26 Registered or Trademark Name Generic Name (if applicable … undergoing PTCA or atherectomy 27 Registered or Trademark Name Generic Name (if applicable … to reduce the risk of bleeding 28 Registered or Trademark Name Generic Name (if applicable

110. Transparency of Reporting Requirements: Effectiveness of Treatments Options for the Prevention of Complications and Treatment of Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research-protocol.pdf
     September 01, 2016 - As of 2008, basic summaries of trial results must be submitted for certain applicable trials, including … DISEASE] AND NOT pain [DISEASE] =97 studies (64 completed studies and 33 ongoing studies) 50 of which applicable

111. Registry of Patient Registries (RoPR): Project Overview (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries_research-2012-3_0.pdf
     January 01, 2012 - Not applicable. Methods. … the RoPR to understand a registry’s purpose, design, clinical focus, goals, targeted outcomes (if applicable

112. PowerPoint Presentation
     effectivehealthcare.ahrq.gov/sites/default/files/ebc-webinar-slides.pptx
     June 01, 2014 - electronics and computers Presenter and Controller: Janette Capaci 30 Enhances Care Delivery Applicable … Presenter and Controller: Janette Capaci 33 Team Challenges Accessible to all members of the team Applicable

113. EBC-webinar-slides (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ebc-webinar-slides.pdf
     June 01, 2014 -  to  electronics  and  computers     Slide  31   Enhances  Care  Delivery    Applicable … Slide  34   Team  Challenges    Accessible  to  all  members  of  the  team    Applicable

114. The Performance of Fusion Procedures for Degenerative Disease of teh Lumbar Spine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/lumbar-fusion-protocol.pdf
     June 20, 2024 - Interventions ALL Key Questions • FDA approved devices or materials (or in Phase III trials) as applicable … ALL Key Questions • Devices or materials that are not FDA approved or in Phase III trials (as applicable … Comparators ALL Key Questions • FDA approved devices or materials (or in Phase III trials) as applicable … care, usual care • Devices or materials that are not FDA approved or in Phase III trials (as applicable … • Consistency (consistent, inconsistent, or unknown/not applicable) o This is the degree to which

115. App-F2-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
     May 29, 2025 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…

116. Disparities-Quality-Improvement Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
     August 01, 2012 - Of the other two studies, one’s results are applicable to patients in academic primary care practices … , and the other’s results are applicable to academic or community hospitals. … The results may or may not be applicable to other populations in other regions. … The usual-care comparators described in these studies may not be applicable to other settings and regions … As much diabetes care is delivered in primary care ambulatory settings, the evidence would be applicable

117. Research White Paper Managing Missing Data in Patient Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
     February 01, 2018 - The topics discussed are applicable to both retrospective and prospective designs and cover both primary … In addition, CRFs should include response options for ‘not applicable,’ thus allowing the registry to … distinguish between data that are missing because they are not applicable for some patients (e.g., … Ideally, a feasibility assessment will be conducted in all or some of the data to scan the values within applicable … As an example, in observational studies, data can be missing, unknown or even not applicable for certain

118. Technical-Brief-31-Mobile-Health-Applications-For-Self-Management-Of-Diabetes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tech-brief-31-mobile-applications-self-mgmt.pdf
     May 01, 2018 - Therefore, the results of this study are applicable when Glucose Buddy is used in combination with text … Therefore, the results of this study are applicable when Diabetes Manager is used in addition to scheduled … Thus, the results of this study are applicable when DID is used in concert with a 2-week course with … high-density lipoprotein; I=intervention; I/E=inclusion/exclusion; LDL=low-density lipoprotein; NA=not applicable … pressure; HDL=high density lipoprotein; I/E=inclusion/exclusion; LDL=low-density lipoprotein; NA=not applicable

119. App-F2-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
     May 29, 2025 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…

120. Minimal Modeling Approaches to Value of Information Analysis for Health Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-value-of-information_research.pdf
     June 01, 2011 - In practice, the minimal modeling approach is most likely to be applicable to interventions for which … Rhythm Management; CI = confidence interval; ICER = incremental cost-effectiveness ratio; NA: not applicable … new analyses suggest several general situations in which minimal modeling approaches may be readily applicable